BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Net income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $835M | −45.5% | −20.2% | −9.6% |
| Net income (TTM) | $835M |
|---|---|
| YoY | −45.5% |
| 5-year CAGR | −20.2% |
| 10-year CAGR | −9.6% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $1.3B | −20.8% |
| 2024 | $1.6B | +40.6% |
| 2023 | $1.2B | −61.9% |
| 2022 | $3.0B | +95.8% |
| 2021 | $1.6B | −61.1% |
| 2020 | $4.0B | −32.1% |
| 2019 | $5.9B | +32.9% |
| 2018 | $4.4B | +74.5% |
| 2017 | $2.5B | −31.4% |
| 2016 | $3.7B | +4.4% |
| 2015 | $3.5B | +20.9% |
| 2014 | $2.9B | +57.6% |
| 2013 | $1.9B | +34.9% |
| 2012 | $1.4B | +11.8% |
| 2011 | $1.2B | +22.8% |
| 2010 | $1.0B | +3.6% |
| 2009 | $970M | +23.9% |
| 2008 | $783M | +22.7% |
| 2007 | $638M | — |